Apogen Biotechnologies LLC is categorized under Services (Unclassified) in Saint Paul, MN and active since 2011.
Apogen Biotechnologies LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Services (Unclassified) business, which does work in the B2B market, and is classified as a Services (Unclassified), under code number 541990 by the NAICS.
If you are seeking more information, feel free to contact Arvine Raghavan at the company’s single location by writing to 1396 Canfield Avenue, Saint Paul, Minnesota MN 55108 or by phoning (651) 428-8157. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Apogen Biotechnologies LLC |
| Contact Person: | Arvine Raghavan |
| Address: | 1396 Canfield Avenue, Saint Paul, Minnesota 55108 |
| Phone Number: | (651) 428-8157 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Services (Unclassified) |
| SIC Code: | 8999 |
| NAICS Code: | 541990 |
| Share This Business: |
Apogen Biotechnologies LLC was started in 2011 to provide professional Services (Unclassified) under the SIC code 8999 and NAICS code 541990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Arvine Raghavan for inquiries that concern Apogen Biotechnologies LLC by calling the company number (651) 428-8157, as your correspondence is most welcome. Additionally, the physical location of the single location of Apogen Biotechnologies LLC can be found at the coordinates 44.979965,-93.159063 as well as the street address 1396 Canfield Avenue in Saint Paul, Minnesota 55108.
For its online presence, you may visit Apogen Biotechnologies LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.